Online First »

REMS Generic Drug Rule Costing Consumers Billions?

According to a report released by the Generic Pharmaceutical Association (GPhA), risk evaluation and mitigation strategies (REMS), aimed at curbing distribution of dangerous medicines, have been used to prevent generic drug-makers from obtaining the drugs in order to test their own versions, which is required for FDA approval.

This has delayed the arrival of 40 potential generic drugs to market, costing an estimated $5.4 billion a year for consumers, according to a report by Matrix Global Advisors and the generic drug trade group.

Online Exclusive »

WHO Releases New HIV Guidelines

With the 20th Annual International AIDS Conference currently underway in Melbourne, Australia, the World Health Organization (WHO) indicated that 5 marginalized groups are disproportionately driving the global HIV epidemic in newly released guidelines.

In a news conference, Fabio Mesquita, MD, director, HIV and viral hepatitis program, Ministry of Health, Sao Paulo, Brazil, said, “If we do not address key affected populations, we [will not] reach our goal of controlling the epidemic by the year 2030.”

Current Issue

Cover Story »

Inspector General Finds Problems at US Department of Veterans Affairs’ Medical Facilities

Since 2005, the Office of the Inspector General (OIG) has issued 18 reports indicating scheduling issues, long wait times, and subpar patient care at US Department of Veterans Affairs (VA) facilities throughout the United States. None received as much attention or led to as much political scrutiny as the interim report from May 28.

Supplements and Special Projects